Jeffrey Marx to Aged, 80 and over
This is a "connection" page, showing publications Jeffrey Marx has written about Aged, 80 and over.
Connection Strength
0.183
-
Blaha GR, Tilton EP, Barouch FC, Marx JL. Randomized trial of anesthetic methods for intravitreal injections. Retina. 2011 Mar; 31(3):535-9.
Score: 0.045
-
Anderson C, Pahk P, Blaha GR, Spindel GP, Alster Y, Rafaeli O, Marx JL. Preferential Hyperacuity Perimetry to detect hydroxychloroquine retinal toxicity. Retina. 2009 Sep; 29(8):1188-92.
Score: 0.041
-
Blaha GR, Wertz FD, Marx JL. Profound choroidal hypoperfusion after combined photodynamic therapy and intravitreal triamcinolone acetonide. Ophthalmic Surg Lasers Imaging. 2008 Jan-Feb; 39(1):6-11.
Score: 0.036
-
Yepremyan M, Wertz FD, Tivnan T, Eversman L, Marx JL. Early treatment of cystoid macular edema secondary to branch retinal vein occlusion with intravitreal triamcinolone acetonide. Ophthalmic Surg Lasers Imaging. 2005 Jan-Feb; 36(1):30-6.
Score: 0.030
-
Moshfeghi DM, Hariprasad SM, Marx JL, Thompson D, Soo Y, Gibson A, Saroj N, Vitti R, Heier JS. Effect of Fluid Status at Week 12 on Visual and Anatomic Outcomes at Week 52 in the VIEW 1 and 2 Trials. Ophthalmic Surg Lasers Imaging Retina. 2016 Mar; 47(3):238-44.
Score: 0.016
-
Boyer DS, Beer PM, Joffe L, Koester JM, Marx JL, Weisberger A, Yoser SL. Effect of adjunctive diclofenac with verteporfin therapy to treat choroidal neovascularization due to age-related macular degeneration: phase II study. Retina. 2007 Jul-Aug; 27(6):693-700.
Score: 0.009
-
Brown BA, Marx JL, Ward TP, Hollifield RD, Dick JS, Brozetti JJ, Howard RS, Thach AB. Homocysteine: a risk factor for retinal venous occlusive disease. Ophthalmology. 2002 Feb; 109(2):287-90.
Score: 0.006